TrialStem cell research & therapy2025

Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections.

Carlos Gallego-Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.